相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 is an appropriate name for the new coronavirus
Yuntao Wu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship
Volodymyr V. Oberemok et al.
INFLAMMATION RESEARCH (2020)
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes A Randomized Clinical Trial
Grace L. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
China is promoting coronavirus treatments based on unproven traditional medicines
David Cyranoski
NATURE (2020)
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Firas A. Rabi et al.
PATHOGENS (2020)
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Ruodan Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus
Marie Luisa Schmidt et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A review on current status of antiviral siRNA
Abid Qureshi et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread
P. Karayiannis
HEPATOLOGY INTERNATIONAL (2017)
Production of virus-like particles for vaccines
J. Fuenmayor et al.
NEW BIOTECHNOLOGY (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP)
Katie R. Young et al.
FASEB JOURNAL (2015)
Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate
Diego Fontana et al.
VACCINE (2015)
Safety and immunogenicity of a virus-like, particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
Jenny G. H. Low et al.
VACCINE (2014)
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Christine M. Thompson et al.
VIROLOGY JOURNAL (2013)
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
Stefan W. Metz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Virus-like particle (VLP)-based vaccines for pandemic influenza
Constantino López-Macías
Human Vaccines & Immunotherapeutics (2012)
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice
Chuan Li et al.
VACCINE (2010)
Influenza virus-like particle vaccines
Joel R. Haynes
EXPERT REVIEW OF VACCINES (2009)
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice
Marc-Andre D'Aoust et al.
PLANT BIOTECHNOLOGY JOURNAL (2008)
Evaluation of influenza virus-like particles and Novasorne adjuvant as candidate vaccine for avian influenza
Peter Pushko et al.
VACCINE (2007)
Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens
Jamie P. Phelps et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L. Buonaguro et al.
JOURNAL OF VIROLOGY (2006)
Virus-like particles production in green plants
Luca Santi et al.
METHODS (2006)
Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: Principles, practices, and prospects
L Li et al.
CLINICAL INFECTIOUS DISEASES (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
